The invention concerns novel recombinant viruses and their use for gene-transfer
into nerve cells of vertebrates. The invention also concerns pharmaceutical compositions
comprising said recombinant viruses. More particularly, the invention concerns
novel vectors derived from baculoviruses and their use for treating diseases of
the nervous system of vertebrates.